Sunirudha Pharma Private Limited
About Sunirudha Pharma Private Limited
Data last updated:
Sunirudha Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24304TN2017PTC121075.
The company has an authorised share capital of ₹26 Cr and a paid-up capital of ₹25.26 Cr. It is led by directors Purushottam Ramdas Adep and Godrej Baman Irani.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 13 Old No 5 A – 3 Sai Niketan Circular Road United India Colony Kodambakkam, Chennai, Tamil Nadu, India – 600024.
As per the financials filed for FY 2025, the company reported a revenue of ₹86,190, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹13,320 (net margin 15.5%) and EBITDA of ₹19,140 (EBITDA margin 22.2%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 3% over five years.
The company has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹25.25 Cr; the latest was in October 2017. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Linear Pharma Private Limited with revenue of ₹89,127.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Sunirudha Pharma has one previous CIN (Corporate Identification Number): U24304PN2017PTC171725. The current CIN is U24304TN2017PTC121075, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24304TN2017PTC121075 | Current |
| U24304PN2017PTC171725 | Previous |
Contact details
Sunirudha Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered Address13 Old No 5 A – 3 Sai Niketan Circular Road United India Colony Kodambakkam, Chennai, Tamil Nadu, India – 600024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sunirudha Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sunirudha Pharma Private Limited
FY 2025 filings availableSunirudha Pharma Private Limited reported revenue of ₹86,190 (down 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 22% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19,140 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13,320 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.2% | ||||
| Net Profit Margin | 15.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sunirudha Pharma Private Limited, buy the company report.
Board of directors of Sunirudha Pharma Private Limited
Sunirudha Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Purushottam Ramdas Adep Also directs: Videsh Hospitality Private Limited, Yogavid Biotech Private Limited, Chakan Investment Private Limited and 1 more | Director | 31 Jul 2017 | 9 Years 2 Months | Current |
| Godrej Baman Irani Also directs: Cortesia Pharma Private Limited, Jivkalpa Pharma Private Limited, Fortune Intercontinental Private Limited and 3 more | Director | 31 Jul 2017 | 9 Years 2 Months | Current |
Peer comparison
Sunirudha Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Linear Pharma Private Limited | ₹89,127 (FY 2025) | 6.0% | Delhi, India | |||
| Ombalaji Meditech Private Limited | ₹87,297 (FY 2025) | Gurgaon, Haryana, India | ||||
| Neetisha Medical Infotech Private Limited | ₹86,757 (FY 2021) | -98.0% | Ahmedabad, Gujarat, India | |||
| Chian Bio Private Limited | ₹86,730 (FY 2025) | -78.0% | Hyderabad, Telangana, India | |||
| Vakzine Pharma Private Limited | ₹86,400 (FY 2025) | -22.0% | Chennai, Tamil Nadu, India | |||
| Sunirudha Pharma Private Limitedthis company | ₹86,190 (FY 2025) | ₹13,320 | 15.5% | -22.0% | Chennai, Tamil Nadu, India | |
| Yogavid Biotech Private Limited | ₹85,670 (FY 2025) | -12.0% | Chennai, Tamil Nadu, India | |||
| Lifecore Pharmaceuticals Private Limited | ₹85,010 (FY 2025) | Puducherry, India | ||||
| Sheer Health Pharmaceuticals Private Limited | ₹84,989 (FY 2023) | -62.0% | Roorkee, Uttarakhand, India | |||
| Sanex Pharmaceuticals Limited | ₹83,905 (FY 2025) | 228.0% | Kolkata, West Bengal, India | |||
| Oxonex Biological Private Limited | ₹83,874 (FY 2024) | Bangalore, Karnataka, India |
To see the full peer comparison of Sunirudha Pharma Private Limited, buy the company report.
Auditor
Sunirudha Pharma Private Limited is audited by PATKI & SOMAN for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PATKI & SOMAN | FY 2021 | 107830W |
Shareholding
The shareholding of Sunirudha Pharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sunirudha Pharma Private Limited, buy the company report.
Deals & funding
Sunirudha Pharma Private Limited has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹25.25 Cr; the latest was in October 2017.
Deals on record (2 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2017 | Funding round | ₹2.99 Cr | Investors: Chanda Investment and Trading Company Private Limited , Poonawalla Credit Private Limited , Agnimitra Trading and Finance Pvt.Ltd. |
| Aug 2017 | Secondary share transfer | Undisclosed | Buyer: Chakan Investment Private Limited , Adurjee & Bros Private Limited Seller: 2 individuals |
To see the full deal history of Sunirudha Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Sunirudha Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunirudha Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sunirudha Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sunirudha Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Godrej Baman Irani was appointed as Director on 31 Jul 2017.
Frequently asked questions
Sunirudha Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 July 2017 (9+ years old) and is registered under CIN U24304TN2017PTC121075.
Sunirudha Pharma has 2 current directors:
- Purushottam Ramdas Adep - Director
- Godrej Baman Irani - Director
The latest financial statements of Sunirudha Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Sunirudha Pharma is U24304TN2017PTC121075. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunirudha Pharma was incorporated on 31 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chennai.
Sunirudha Pharma has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹25.25 Cr; the latest was in October 2017.
The peers of Sunirudha Pharma by revenue are Linear Pharma Private Limited, Ombalaji Meditech Private Limited, Neetisha Medical Infotech Private Limited, Chian Bio Private Limited, Vakzine Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Godrej Baman Irani was appointed as Director on 31 Jul 2017. Purushottam Ramdas Adep was appointed as Director on 31 Jul 2017.
The registered office of Sunirudha Pharma is at 13 Old No 5 A – 3 Sai Niketan Circular Road United India Colony Kodambakkam, Chennai, Tamil Nadu, India – 600024.
Sunirudha Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Sunirudha Pharma is active non-compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.